Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alternativeName |
Champix
Varenicline tartrate |
| gptkbp:approvalYear |
2006
|
| gptkbp:ATCCode |
N07BA03
|
| gptkbp:contraindication |
hypersensitivity to varenicline
|
| gptkbp:eliminationHalfLife |
24 hours
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericName |
varenicline
|
| https://www.w3.org/2000/01/rdf-schema#label |
Chantix
|
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:mechanismOfAction |
partial agonist at nicotinic acetylcholine receptors
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:retired |
nitrosamine impurity concerns
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache insomnia neuropsychiatric symptoms abnormal dreams |
| gptkbp:usedFor |
smoking cessation
|
| gptkbp:withdrawn |
gptkb:Canada
|
| gptkbp:bfsParent |
gptkb:Viatris
|
| gptkbp:bfsLayer |
8
|